Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.01B | 10.44B | 12.31B | 12.52B | 11.56B | 10.28B |
Gross Profit | 2.57B | 2.01B | 3.78B | 4.16B | 3.61B | 2.77B |
EBITDA | 206.58M | 40.97M | 1.20B | 1.89B | 1.50B | 801.38M |
Net Income | -232.20M | -539.10M | 338.27M | 1.00B | 790.49M | 539.97M |
Balance Sheet | ||||||
Total Assets | 17.40B | 16.78B | 18.54B | 17.46B | 15.72B | 15.28B |
Cash, Cash Equivalents and Short-Term Investments | 6.77B | 7.04B | 7.47B | 7.04B | 5.99B | 5.08B |
Total Debt | 2.43B | 2.33B | 2.90B | 3.54B | 4.10B | 4.69B |
Total Liabilities | 9.72B | 9.52B | 10.30B | 9.88B | 9.17B | 9.57B |
Stockholders Equity | 7.68B | 7.25B | 8.24B | 7.58B | 6.54B | 5.71B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 602.21M | 1.03B | 1.83B | 1.59B | -44.89M |
Operating Cash Flow | 0.00 | 605.10M | 1.06B | 1.84B | 1.63B | 23.61M |
Investing Cash Flow | 0.00 | -54.93M | -28.00M | -14.19M | 20.76M | 169.00M |
Financing Cash Flow | 0.00 | -939.22M | -960.92M | -957.33M | -951.55M | -329.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | ¥343.76B | 10.59 | -2.88% | 2.57% | 11.81% | -7.17% | |
55 Neutral | ¥10.67B | ― | ― | 109.03% | 98.53% | ||
54 Neutral | ¥7.45B | ― | 4.85% | -15.20% | -259.37% | ||
54 Neutral | ¥7.76B | 55.07 | ― | -92.17% | -1648.96% | ||
47 Neutral | ¥8.23B | ― | -148.36% | ― | 22.93% | 47.73% | |
41 Neutral | ¥7.10B | ― | ― | -97.61% | 14.80% |
Linical Co., Ltd. announced a resolution to distribute retained earnings, declaring a year-end dividend of JPY 16.00 per share for the fiscal year ended March 31, 2025. This decision reflects the company’s commitment to balancing corporate growth with shareholder returns, as dividends are paid from retained earnings based on board resolutions.
Linical Co., Ltd. reported a significant decline in its financial performance for the fiscal year ending March 31, 2025, with net sales dropping by 15.2% and a net loss of ¥539 million. Despite the downturn, the company forecasts a recovery in the next fiscal year with an expected 7.3% increase in net sales and a return to profitability.